ATE205470T1 - Fluoriertes propranolol und ahnliche verfahren - Google Patents
Fluoriertes propranolol und ahnliche verfahrenInfo
- Publication number
- ATE205470T1 ATE205470T1 AT96940758T AT96940758T ATE205470T1 AT E205470 T1 ATE205470 T1 AT E205470T1 AT 96940758 T AT96940758 T AT 96940758T AT 96940758 T AT96940758 T AT 96940758T AT E205470 T1 ATE205470 T1 AT E205470T1
- Authority
- AT
- Austria
- Prior art keywords
- fluorinated
- propranolol
- presented
- similar methods
- drugs
- Prior art date
Links
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical class C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 title abstract 5
- 230000003078 antioxidant effect Effects 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 239000003963 antioxidant agent Substances 0.000 abstract 2
- 230000000903 blocking effect Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229960003712 propranolol Drugs 0.000 abstract 2
- 239000002876 beta blocker Substances 0.000 abstract 1
- 229940097320 beta blocking agent Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US683595P | 1995-11-16 | 1995-11-16 | |
| US879095P | 1995-12-18 | 1995-12-18 | |
| PCT/US1996/017679 WO1997018184A1 (en) | 1995-11-16 | 1996-11-16 | Fluorinated propranolol and related methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE205470T1 true ATE205470T1 (de) | 2001-09-15 |
Family
ID=26676127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96940758T ATE205470T1 (de) | 1995-11-16 | 1996-11-16 | Fluoriertes propranolol und ahnliche verfahren |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5776985A (de) |
| EP (1) | EP0883596B1 (de) |
| JP (1) | JP2000500451A (de) |
| AT (1) | ATE205470T1 (de) |
| DE (1) | DE69615221T2 (de) |
| DK (1) | DK0883596T3 (de) |
| ES (1) | ES2163661T3 (de) |
| PT (1) | PT883596E (de) |
| WO (1) | WO1997018184A1 (de) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL300886A (de) * | 1962-11-23 |
-
1996
- 1996-11-14 US US08/748,894 patent/US5776985A/en not_active Expired - Fee Related
- 1996-11-16 WO PCT/US1996/017679 patent/WO1997018184A1/en not_active Ceased
- 1996-11-16 PT PT96940758T patent/PT883596E/pt unknown
- 1996-11-16 AT AT96940758T patent/ATE205470T1/de not_active IP Right Cessation
- 1996-11-16 DE DE69615221T patent/DE69615221T2/de not_active Expired - Fee Related
- 1996-11-16 ES ES96940758T patent/ES2163661T3/es not_active Expired - Lifetime
- 1996-11-16 JP JP9518905A patent/JP2000500451A/ja not_active Ceased
- 1996-11-16 DK DK96940758T patent/DK0883596T3/da active
- 1996-11-16 EP EP96940758A patent/EP0883596B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0883596B1 (de) | 2001-09-12 |
| US5776985A (en) | 1998-07-07 |
| DE69615221T2 (de) | 2002-06-13 |
| DK0883596T3 (da) | 2002-01-21 |
| EP0883596A4 (de) | 1999-05-06 |
| EP0883596A1 (de) | 1998-12-16 |
| WO1997018184A1 (en) | 1997-05-22 |
| JP2000500451A (ja) | 2000-01-18 |
| PT883596E (pt) | 2002-02-28 |
| DE69615221D1 (de) | 2001-10-18 |
| ES2163661T3 (es) | 2002-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9301634A (es) | Quinuclidinas peptidicas. | |
| ATE184598T1 (de) | Enniatine und enniatinderivate zur bekämpfung von endoparasiten | |
| RU94038043A (ru) | Применение замещенных производных аденина для лечения множественного склероза | |
| ES2071486T3 (es) | Derivado de la 5h-pirrolo(3,4-b)pirazina opticamente activa, su preparacion y las composiciones farmaceuticas que le contienen. | |
| AR010062A1 (es) | Nuevos benzamidaldehidos y su utilizacion | |
| ES2167377T3 (es) | Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos. | |
| ES2152483T3 (es) | Aplicacion terapeutica en anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de celulas b. | |
| ES2093694T3 (es) | Nuevos derivados de dihidro-isoquinoleina. | |
| ES2161697T3 (es) | Peptidos agonistas de amilina y usos de los mismos. | |
| EP0657486A3 (de) | Fluormodifiziertes Silikon, Verfahren zu seiner Herstellung und dieses enthaltende Kosmetika. | |
| ES2170102T3 (es) | Aminociclohexilesteres y utilizacion de los mismos. | |
| ES2056180T3 (es) | Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina. | |
| ES2192839T3 (es) | Timosina beta 4 oxidada. | |
| UA29466C2 (uk) | Фармацевтична композиція з антипухлинною активністю | |
| ES2164914T3 (es) | Medicamentos de inmunoterapia que contienen anticuerpos que detectan especificamente el antigeno mhcii del paciente a tratar. | |
| ATE180781T1 (de) | Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung | |
| ES2120962T3 (es) | Composicion antivirica. | |
| EA199900450A1 (ru) | Агент, индуцирующий апоптоз | |
| ES2100689T3 (es) | Asociacion sinergizante que tiene un efecto antagonista de los receptores nk1 y nk2. | |
| DK578887A (da) | Antihypertensiva | |
| AR008860A1 (es) | Empleo de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica | |
| ATE205470T1 (de) | Fluoriertes propranolol und ahnliche verfahren | |
| NO913117D0 (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
| MX9305720A (es) | Derivados novedosos de tiomarinol, y procedimientos para su preparacion. | |
| ES2032797T3 (es) | Agente terapeutico para el tratamiento de la enfermedad ulcera peptica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |